5 Followers

#Leqembi

With stories from Non-Infectious Diseases, Neurological Disorders, Neurodegenerative Disease, Cognitive Disorders, Dementia, Alzheimer's Disease, Medical Conditions, Health, Science

Get the latest articles, videos, and news about Leqembi on Flipboard. Discover our growing collection of curated stories on Leqembi.

Mitch Sayler
flipped into INVEST - GROWTH & DIVIDENDS
3 days ago
Eli Lilly's Alzheimer's Drug Obtains FDA Approval. Here's Why the Stock Isn't Taking Off.
The Motley Fool - David Jagielski
The news likely didn't come as a big surprise to investors. Eli Lilly (LLY 1.53%) received some great news from regulators last week: Its Alzheimer's …
BioPharma Dive
flipped into BioPharma Dive
4 days ago
Leqembi sales inch higher; Spark’s pivot leads to layoffs
biopharmadive.com - BioPharma Dive staff
Today, a brief rundown of news from Eisai, Spark Therapeutics and Ipsen as well as updates from Element Biosciences and Novartis that you may have …
Investing.com Australia
flipped into Australia Financial Markets
5 days ago
Biogen: RBC says 'very likely' that Leqembi will be approved in Europe
Investing.com Australia - Sam Boughedda
RBC Capital analysts express strong confidence that Biogen's (NASDAQ:BIIB) Alzheimer's drug Leqembi will receive a positive recommendation from the …
Investing.com
flipped into Stock Markets
US FDA approves Lilly's Alzheimer's drug
investing.com - Reuters
The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly (NYSE:LLY)'s donanemab for patients with early Alzheimer's, making …
Sean Kernan
flipped into World and Breaking News
'Microdosing' candies linked to illness, death, and a new Alzheimer's drug: A look at health stories you may have missed
yahoo.com - Kaitlin Reilly
Hello, health and wellness readers. My name is Kaitlin, your guide to the latest health news you may have missed. First, let’s take a look at what our …
5 days ago
UAlbany’s early Alzheimer’s screening tool shows promising results
news10.com - by: Trishna Begam
ALBANY, N.Y. (NEWS10) — The Food and Drug Administration recently approved a new Alzheimer’s drug that aims to delay the progression of the disease. …

See more stories

#Leqembi

5 Followers

More stories from Non-Infectious Diseases

More stories from Neurological Disorders

More stories from Neurodegenerative Disease